Cardeas Pharma Company
Cardeas Pharma specializes in early-phase development of inhaled antibiotics to treat respiratory infections.
Employee Number:
11-50
Funding Status:
Early Stage Venture
Headquarters:
Seattle, Washington, United States
Technology:
Biologics
Estimated Revenue:
$1M to $10M
Founded Date:
2010
Industry:
PharmTech